vs

OMNICELL, INC.(OMCL)与UiPath, Inc.(PATH)财务数据对比。点击上方公司名可切换其他公司

UiPath, Inc.的季度营收约是OMNICELL, INC.的1.3倍($411.1M vs $309.9M),UiPath, Inc.净利率更高(48.4% vs 3.7%,领先44.7%),UiPath, Inc.同比增速更快(15.9% vs 14.9%),OMNICELL, INC.自由现金流更多($38.6M vs $25.1M),过去两年OMNICELL, INC.的营收复合增速更高(5.8% vs 0.7%)

Omnicell是总部位于美国加州山景城的跨国医疗科技企业,专注于为医院及各类医疗机构提供药品管理自动化系统,同时面向零售药房推出用药依从性包装与患者互动软件,旗下产品使用Omnicell及EnlivenHealth两大品牌。

UiPath是一家全球化软件企业,专注于开发人工智能、智能自动化及流程编排类软件,其产品支持用户搭建与调度AI代理,实现复杂业务流程、工作流的自动化运行,助力各行业客户提升运营效率、降低人力成本。

OMCL vs PATH — 直观对比

营收规模更大
PATH
PATH
是对方的1.3倍
PATH
$411.1M
$309.9M
OMCL
营收增速更快
PATH
PATH
高出1.0%
PATH
15.9%
14.9%
OMCL
净利率更高
PATH
PATH
高出44.7%
PATH
48.4%
3.7%
OMCL
自由现金流更多
OMCL
OMCL
多$13.5M
OMCL
$38.6M
$25.1M
PATH
两年增速更快
OMCL
OMCL
近两年复合增速
OMCL
5.8%
0.7%
PATH

损益表 — Q1 FY2026 vs Q3 FY2026

指标
OMCL
OMCL
PATH
PATH
营收
$309.9M
$411.1M
净利润
$11.4M
$198.8M
毛利率
45.3%
83.3%
营业利润率
60.1%
3.2%
净利率
3.7%
48.4%
营收同比
14.9%
15.9%
净利润同比
1966.2%
每股收益(稀释后)
$0.25
$0.37

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
OMCL
OMCL
PATH
PATH
Q1 26
$309.9M
Q4 25
$314.0M
$411.1M
Q3 25
$310.6M
$361.7M
Q2 25
$290.6M
$356.6M
Q1 25
$269.7M
$423.6M
Q4 24
$306.9M
$354.7M
Q3 24
$282.4M
$316.3M
Q2 24
$276.8M
$335.1M
净利润
OMCL
OMCL
PATH
PATH
Q1 26
$11.4M
Q4 25
$198.8M
Q3 25
$5.5M
$1.6M
Q2 25
$5.6M
$-22.6M
Q1 25
$-7.0M
$51.8M
Q4 24
$-10.7M
Q3 24
$8.6M
$-86.1M
Q2 24
$3.7M
$-28.7M
毛利率
OMCL
OMCL
PATH
PATH
Q1 26
45.3%
Q4 25
41.5%
83.3%
Q3 25
43.3%
82.2%
Q2 25
43.9%
82.1%
Q1 25
41.1%
84.8%
Q4 24
46.2%
82.0%
Q3 24
43.3%
80.0%
Q2 24
41.3%
83.5%
营业利润率
OMCL
OMCL
PATH
PATH
Q1 26
60.1%
Q4 25
0.1%
3.2%
Q3 25
2.7%
-5.6%
Q2 25
2.8%
-4.6%
Q1 25
-4.3%
7.9%
Q4 24
4.0%
-12.2%
Q3 24
2.3%
-32.7%
Q2 24
1.2%
-14.8%
净利率
OMCL
OMCL
PATH
PATH
Q1 26
3.7%
Q4 25
48.4%
Q3 25
1.8%
0.4%
Q2 25
1.9%
-6.3%
Q1 25
-2.6%
12.2%
Q4 24
-3.0%
Q3 24
3.1%
-27.2%
Q2 24
1.3%
-8.6%
每股收益(稀释后)
OMCL
OMCL
PATH
PATH
Q1 26
$0.25
Q4 25
$-0.05
$0.37
Q3 25
$0.12
$0.00
Q2 25
$0.12
$-0.04
Q1 25
$-0.15
$0.09
Q4 24
$0.34
$-0.02
Q3 24
$0.19
$-0.15
Q2 24
$0.08
$-0.05

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
OMCL
OMCL
PATH
PATH
现金及短期投资手头流动性
$239.2M
$1.4B
总债务越低越好
股东权益账面价值
$1.3B
$1.9B
总资产
$2.0B
$2.9B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
OMCL
OMCL
PATH
PATH
Q1 26
$239.2M
Q4 25
$196.5M
$1.4B
Q3 25
$180.1M
$1.4B
Q2 25
$399.0M
$1.6B
Q1 25
$386.8M
$1.6B
Q4 24
$369.2M
$1.6B
Q3 24
$570.6M
$1.7B
Q2 24
$556.8M
$1.9B
股东权益
OMCL
OMCL
PATH
PATH
Q1 26
$1.3B
Q4 25
$1.2B
$1.9B
Q3 25
$1.2B
$1.7B
Q2 25
$1.3B
$1.7B
Q1 25
$1.3B
$1.8B
Q4 24
$1.2B
$1.7B
Q3 24
$1.2B
$1.8B
Q2 24
$1.2B
$2.0B
总资产
OMCL
OMCL
PATH
PATH
Q1 26
$2.0B
Q4 25
$2.0B
$2.9B
Q3 25
$1.9B
$2.6B
Q2 25
$2.1B
$2.6B
Q1 25
$2.2B
$2.9B
Q4 24
$2.1B
$2.7B
Q3 24
$2.3B
$2.7B
Q2 24
$2.3B
$2.8B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
OMCL
OMCL
PATH
PATH
经营现金流最新季度
$54.5M
$28.3M
自由现金流经营现金流 - 资本支出
$38.6M
$25.1M
自由现金流率自由现金流/营收
12.5%
6.1%
资本支出强度资本支出/营收
0.8%
现金转化率经营现金流/净利润
4.80×
0.14×
过去12个月自由现金流最近4个季度
$110.8M

8季度趋势,按日历期对齐

经营现金流
OMCL
OMCL
PATH
PATH
Q1 26
$54.5M
Q4 25
$30.4M
$28.3M
Q3 25
$28.3M
$41.6M
Q2 25
$42.8M
$119.0M
Q1 25
$25.9M
$146.1M
Q4 24
$56.3M
$28.1M
Q3 24
$22.8M
$46.4M
Q2 24
$58.7M
$100.0M
自由现金流
OMCL
OMCL
PATH
PATH
Q1 26
$38.6M
Q4 25
$22.6M
$25.1M
Q3 25
$18.5M
Q2 25
$31.0M
$106.2M
Q1 25
$14.8M
$138.7M
Q4 24
$47.2M
$23.2M
Q3 24
$13.9M
$45.0M
Q2 24
$49.1M
$98.8M
自由现金流率
OMCL
OMCL
PATH
PATH
Q1 26
12.5%
Q4 25
7.2%
6.1%
Q3 25
6.0%
Q2 25
10.7%
29.8%
Q1 25
5.5%
32.7%
Q4 24
15.4%
6.5%
Q3 24
4.9%
14.2%
Q2 24
17.8%
29.5%
资本支出强度
OMCL
OMCL
PATH
PATH
Q1 26
Q4 25
2.5%
0.8%
Q3 25
3.1%
0.0%
Q2 25
4.1%
3.6%
Q1 25
4.1%
1.7%
Q4 24
3.0%
1.4%
Q3 24
3.1%
0.4%
Q2 24
3.5%
0.4%
现金转化率
OMCL
OMCL
PATH
PATH
Q1 26
4.80×
Q4 25
0.14×
Q3 25
5.18×
26.25×
Q2 25
7.58×
Q1 25
2.82×
Q4 24
Q3 24
2.64×
Q2 24
15.72×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

相关对比